Skip To Main Content
Geeta Devgan on Muck Rack

Geeta Devgan

As seen in: Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Geeta

Contact Geeta, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Avelumab (anti-PD-L1) in platinum-resistant/refractory ovarian cancer: JAVELIN Ovarian 200 Phase III study design

|
By Eric Pujade-Lauraine, Keiichi Fujiwara, Samuel S. Dychter, Geeta Devgan
| Future Medicine Verified
The JAVELIN Ovarian 200 trial discussed in this manuscript is sponsored by Pfizer Inc., New York, NY, USA, and is part of an alliance between Pfizer Inc. and Merck KGaA, Darmstadt, Germany. E Pujade-Lauraine has acted in a consultant/advisory role for AstraZeneca, Pfizer, and Roche and has received travel, accommodation, or expenses from AstraZeneca, Pfizer, and Roche.
Open in Who Shared Issue with article?
See all 1 articles